Top Markets
#1 ADO Protocol ADO Protocol +233.73%
#2 Islamic Coin Islamic Coin +155.42%
#3 GoPlus Security GoPlus Security +60.87%
#4 Verus Coin Verus Coin +33.01%
#5 Starpower Starpower +28.54%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +16.10%
#8 o1.exchange o1.exchange +13.60%
#9 Status Status +11.71%
#10 Lumia Lumia +11.38%
Coin of the day
ADO Protocol ADO Protocol
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
Peringkat dalam Saham #33470
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Harga Saham
$1.69
Terakhir disinkronkan: 2026-08-13
Kapitalisasi Pasar
$7.59M
Perubahan (1 hari)
2.22%
Perubahan (1 tahun)
-84.04%
Negara
CA
Perdagangan InnoCan Pharma Corporation (INNO)

Kategori

Healthcare
Laba untuk InnoCan Pharma Corporation (INNO)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari InnoCan Pharma Corporation, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk InnoCan Pharma Corporation dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN